Science Explorer Back to mapMap
Discussion
Researcher · University College London · United Kingdom

Nicholas McGranahan

Nicholas McGranahan publishes mostly in Cancer Research, Molecular Biology and Oncology, on topics such as Cancer Genomics and Diagnostics, Cancer Immunotherapy and Biomarkers and Lung Cancer Treatments and Mutations.

ORCID 0000-0001-9537-4045 OpenAlex
World rank
#2,749
of 7,710,434 ranked researchers
Rank in United Kingdom
#178
of 367,258
Works
516
Citations
45k
Citations per work
87.4
h-index
80
i10-index 140Top 0.5% in Cancer Research
Nicholas McGranahan

What does Nicholas McGranahan research?

Nicholas McGranahan's work is mostly in Biochemistry, Genetics and Molecular Biology (49%), Medicine (27%), Immunology and Microbiology (8%).

Life Sciences: 296 works · 57.4% of their workBiochemistry, Genetics and Molecular Biology: 254 works · 49.2% of their workCancer Research: 119 works · 23.1% of their workMolecular Biology: 117 works · 22.6% of their workGenetics: 18 works · 3.5% of their workImmunology and Microbiology: 42 works · 8.2% of their workImmunology: 42 works · 8.2% of their workHealth Sciences: 138 works · 26.7% of their workMedicine: 138 works · 26.7% of their workOncology: 76 works · 14.8% of their workPulmonary and Respiratory Medicine: 61 works · 11.9% of their workEverything else: 82 works · 15.9% of their workTHEIR WORKNicholasMcGranahan516works
Life Sciences57%Health Sciences27%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology25449.2%
    2. Immunology and Microbiology428.2%
    1. Medicine13826.7%
  3. Everything else8215.9%
  1. 1Cancer Research23% of their works
  2. 2Molecular Biology23% of their works
  3. 3Oncology15% of their works
  4. 4Pulmonary and Respiratory Medicine12% of their works
  5. 5Immunology8% of their works
  6. 6Genetics4% of their works

Research topics

Which keywords describe Nicholas McGranahan's research?

The keywords of their largest research topics: Targeted Therapy, Cancer Genomics, Mutational Signatures, Tumor Microenvironment, Immune Checkpoint Blockade, PD-1 and PD-L1, ALK Inhibitors and EGFR Mutations.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 19 words, with their numbers
  1. Targeted Therapy2082 topics
  2. Cancer Genomics1661 topic
  3. Mutational Signatures1661 topic
  4. Tumor Microenvironment792 topics
  5. Immune Checkpoint Blockade611 topic
  6. PD-1 and PD-L1611 topic
  7. ALK Inhibitors421 topic
  8. EGFR Mutations421 topic
  9. Gene Expression382 topics
  10. RNA methylation331 topic
  11. m6A-seq331 topic
  12. Dendritic Cells321 topic
  13. Immunity321 topic
  14. DNA Methylation231 topic
  15. Histone Modification231 topic
  16. Single-Cell201 topic
  17. Transcriptomics201 topic
  18. Cancer181 topic
  19. Ferroptosis181 topic

Where does Nicholas McGranahan work?

Nicholas McGranahan's main affiliation in the publication record is University College London, United Kingdom.

How many publications and citations does Nicholas McGranahan have?

OpenAlex counts 516 works and 45,073 citations for Nicholas McGranahan, an h-index of 80, ranking #2,749 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Nicholas McGranahan. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.